【2024最新】菲律賓SIM卡推薦懶人包！菲律賓網卡怎麼買不踩雷？馬尼拉、宿霧、薄荷島上網實測！

CINQAIR® (reslizumab) Injection | 合法藥品大搜索

CINQAIR® (reslizumab) Injection

WhatisCINQAIR?CINQAIRisaprescriptionmedicineusedwithotherasthmamedicinesforthemaintenancetreatmentofasthmainpeopleaged18yearsofage ...

 CINQAIR® (reslizumab) Injection

IMPORTANT SAFETY INFORMATION

What is the most important information I should know about CINQAIR?

CINQAIR can cause serious side effects, including:

Serious allergic reactions (anaphylaxis). Serious allergic reactions can happen right after you receive your CINQAIR infusion. These reactions can cause death. Allergic reactions sometimes do not happen right away. Your healthcare provider will watch you during and after you receive your CINQAIR infusion for any signs of a reaction.

Serious allergic reactions (anaphylaxis). Serious allergic reactions can happen right after you receive your CINQAIR infusion. These reactions can cause death. Allergic reactions sometimes do not happen right away. Your healthcare provider will watch you during and aft...

閱讀更多

reslizumab asthma Benralizumab reslizumab mechanism of action reslizumab vs mepolizumab reslizumab covid reslizumab injection Mepolizumab reslizumab uses reslizumab台灣 Reslizumab reslizumab dose reslizumab cost Benralizumab benralizumab仿單 mepolizumab機轉 mepolizumab健保 mepolizumab仿單 benralizumab健保 Mepolizumab mepolizumab中文 reslizumab asthma reslizumab mechanism of action reslizumab vs mepolizumab reslizumab covid reslizumab injection reslizumab uses reslizumab台灣 Reslizumab reslizumab dose reslizumab cost Reslizumab trial reslizumab subcutaneous Dupilumab nejm Dupilumab asthma reslizumab cost in india benralizumab cost mepolizumab cost nct01285323 cinqair fasenra cinqair price reslizumab side effects dupilumab cinqaero (reslizumab) reslizumab indication Reslizumab fda Benralizumab FDA NUCALA injection FASENRA injection benralizumab benralizumab mechanism of action dupilumab mechanism of action omalizumab mechanism of action benralizumab brand name what is benralizumab Dupilumab CINQAIR dupilumab vs mepolizumab Mepolizumab benralizumab benralizumab vs dupilumab benralizumab vs omalizumab nucala vs fasenra vs dupixent benralizumab review xolair and dupixent combination EAACI biologicals Guidelines recommendations for severe asthma 氣喘治療指引2020 氣喘治療指引2019 氣喘指引2020 氣喘治療指引2021 台灣氣喘人數 gina氣喘2020 氣喘嚴重度分級 台灣氣喘治療指引 莉那藥膏副作用 氧化鎂是什麼 舒膚通膠液頭皮 肌肉鬆弛劑種類 褪黑激素台灣 安比西林消炎 Ampicillin 500mg 腹寧朗脹氣
Reslizumab | 合法藥品大搜索
Reslizumab is an interleukin-5 antagonist monoclonal antibody. IL-5 is the major cytokine responsible for the growth and differentiation, recruitment, activation, and ... Read More
CINQAIR® (reslizumab) Injection | 合法藥品大搜索
What is CINQAIR? CINQAIR is a prescription medicine used with other asthma medicines for the maintenance treatment of asthma in people aged 18 years of age ... Read More
Reslizumab (Cinqair) | 合法藥品大搜索
由 S Hom 著作 · 2017 · 被引用 18 次 — Reslizumab is an IL-5 antagonist (immunoglobulin G4-kappa). IL-5 is a major cytokine involved in the growth, differentiation, recruitment, activation, and survival of ... Read More
Cinqair (reslizumab) dosing, indications | 合法藥品大搜索
Medscape - Asthma dosing for Cinqair (reslizumab), frequency-based adverse effects, comprehensive interactions, contraindications, pregnancy & lactation ... Read More
The effectiveness of Reslizumab in severe asthma treatment ... | 合法藥品大搜索
由 H Ibrahim 著作 · 2019 · 被引用 14 次 — Reslizumab is a humanized monoclonal antibody directed against Interleukin-5. It binds specifically to IL-5 thereby blocking its biological effects ... Read More
Reslizumab for inadequately controlled asthma with elevated ... | 合法藥品大搜索
由 M Castro 著作 · 2015 · 被引用 874 次 — Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: results from two multicentre, parallel, double-blind, randomised, ... Read More
Reslizumab in patients with inadequately controlled late | 合法藥品大搜索
由 G Brusselle 著作 · 2017 · 被引用 85 次 — Compared with placebo, reslizumab produced larger reductions in asthma exacerbations and larger improvements in lung function in patients ... Read More
Reslizumab | 合法藥品大搜索
Reslizumab is a humanized, IgG4κ monoclonal antibody that inhibits IL-5 binding to the α-subunit of the IL-5 receptor complex on the eosinophil. In contrast to ... Read More
CINQAERO, INN-reslizumab | 合法藥品大搜索
Effect on sputum eosinophils. The effect of reslizumab in patients with asthma and elevated sputum eosinophil counts (at least 3%) was evaluated in a 15-week​, ... Read More
相關資訊整理

【立肺治凍晶注射劑 1.5 毫克】適用於治療結締組織疾病續發肺動脈高血壓之WHO功能分級III和IV的患者，以改善運動能力

藥品名稱:立肺治凍晶注射劑1.5毫克許可證字號:衛部藥輸字第027437號許可證種類:製　劑適應症:適用於治療結締組織疾病續發肺...

【希寧】抗病毒藥物

藥品名稱:希寧許可證字號:衛部藥輸字第027462號許可證種類:原料藥適應症:抗病毒藥物劑型:藥品類別:製劑原料主成分略述:申請...

【坦適寧注射劑】葡萄球菌、鏈球菌、肺炎雙球菌、腦膜炎球菌及其他具有感受性細菌引起之感染症

藥品名稱:坦適寧注射劑許可證字號:衛署藥輸字第014780號許可證種類:製　劑適應症:葡萄球菌、鏈球菌、肺炎雙球菌、腦膜炎球菌...

【安能得微脂體注射劑5毫克/毫升】ONIVYDE (irinotecan微脂體注射劑)適用於轉移性胰腺癌，合併5-fluorouracil和leucovorin治療曾接受過gemcitabine的患者。

藥品名稱:安能得微脂體注射劑5毫克/毫升許可證字號:衛部藥輸字第026655號許可證種類:製　劑適應症:ONIVYDE(irinotecan微脂體...

【瑞塔滋膠囊100公絲】與其他抗反轉錄病毒劑併用，適用於治療第一型人類免疫缺乏病毒感染。

藥品名稱:瑞塔滋膠囊100公絲許可證字號:衛署藥輸字第024095號許可證種類:製　劑適應症:與其他抗反轉錄病毒劑併用，適用於治...

【易莎平注射劑】IXEMPRA合併capecitabine適用於治療對anthracycline和taxane治療有抗藥性，或對taxane有抗藥性又不能接受進一步anthracycline治療的轉移性或局部晚期乳癌患者。

藥品名稱:易莎平注射劑許可證字號:衛署藥輸字第025053號許可證種類:製　劑適應症:IXEMPRA合併capecitabine適用於治療對anthr...

【安肺樂易利達 55/22 mcg 乾粉吸入劑】慢性阻塞性肺病(COPD)患者之氣道阻塞症狀的維持治療

藥品名稱:安肺樂易利達55/22mcg乾粉吸入劑許可證字號:衛部藥輸字第026315號許可證種類:製　劑適應症:慢性阻塞性肺病(COPD)患...

【單水化頭芽胞菌素】葡萄球菌、鏈球菌、肺炎雙球菌、腦膜炎球菌及其他具有感受性細菌引起之感染症

藥品名稱:單水化頭芽胞菌素許可證字號:衛署藥輸字第015618號許可證種類:原料藥適應症:葡萄球菌、鏈球菌、肺炎雙球菌、腦膜炎...

【喜－保身燐糖衣錠】骨折

藥品名稱:喜－保身燐糖衣錠許可證字號:衛署藥製字第021333號許可證種類:製　劑適應症:骨折劑型:藥品類別:須由醫師處方使用主...

【順喘咀嚼錠5毫克】適用於預防與長期治療成人及小兒的氣喘，包括預防日間及夜間氣喘症狀，及防止運動引起的支氣管收縮。緩解成人及小兒的日間及夜間過敏性鼻炎症狀(Allergic Rhinitis)。

藥品名稱:順喘咀嚼錠5毫克許可證字號:衛署藥輸字第025829號許可證種類:製　劑適應症:適用於預防與長期治療成人及小兒的氣喘...

【必希寧注射劑】對benzathine penicillin G具有感受性之菌株所引起之感染症。

藥品名稱:必希寧注射劑許可證字號:衛部藥輸字第026966號許可證種類:製　劑適應症:對benzathinepenicillinG具有感受性之菌株...

【"應元"安力腸溶糖衣錠100公絲(本塞克蘭)】末梢血管循環障礙

藥品名稱:"應元"安力腸溶糖衣錠100公絲(本塞克蘭)許可證字號:衛署藥製字第037594號許可證種類:製　劑適應症:末梢血管循環障...